Clinical Trials
10 trialsNCT00004076 2013-12-19
PNU 166148 in Treating Patients With Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00005996 2013-12-19
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00006085 2013-12-19
CP-609,754 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00006088 2013-09-20
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00020644 2013-08-07
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00248521 2013-08-02
17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00004173 2013-05-15
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00009932 2013-05-15
Combination Chemotherapy in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00544063 2009-12-15
Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00005611 2008-07-24
BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment
National Cancer Institute (NCI)
Phase 1 Unknown